Associate Director, Shared Resource Facilities
Director, Biostatistics Shared Resource Facility
- A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer. Massarweh S, Tham YL, Huang J, Sexton K, Weiss H, Tsimelzon A, Beyer A, Rimawi M, Cai WY, Hilsenbeck S, Fuqua S and Elledge R. Breast Cancer Res Treat 129:819-27, 2011.
- Bayesian Monitoring of a phase II chemoprevention trial in high risk cohorts for prostate cancer. Weiss HL, Urban DA, Grizzle WE, Cronin KA, Freedman LS, Kelloff GJ, Lieberman R. Urology 57(4A):220-223, 2001.
Cancer Center Member
Design and analysis of early phase clinical trials focusing on Bayesian design and interim monitoring. Statistical analysis of transgenic, xenograft and chemically induced mouse models of cancer.
- Translational Oncology
College & Department
- College of Public Health
- College of Medicine
- Department of Biostatistics
- Department of Surgery